Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMP-7 in Osteoarthritis of the Knee
NCT01111045Phase 2Completed
- Sponsor
- Stryker
- Start
- Apr 2010
- Primary completion
- Aug 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bone morphogenetic protein 7 in osteoarthritis (OA) (4 arms), sponsored by Stryker. Primary endpoint: Western Ontario and McMaster Osteoarthritis Index (WOMAC) pain subscale at 24 weeks. Started Apr 2010; status: completed.
02
Drugs
bone morphogenetic protein 7
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01111045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111045.